课题基金 / 基金详情

项目摘要

项目成果

Deborah Merke的其他基金

相似基金

相关文献

中文摘要
翻译
本研究已完成全部16名受试者的入组。获得了所有患者的药代动力学数据。该临床试验已经结束,数据分析正在进行中。chronoccort是一种改良的释放疗法,以一种模仿人体正常昼夜节律(人体自然的24小时激素周期)的方式释放氢化可的松。这种治疗方法有可能帮助患有由于皮质醇缺乏引起的疾病的患者:先天性肾上腺增生和肾上腺功能不全。每一种疾病都需要终身治疗,这种新的给药方法有可能显著改善患者的生活。
英文摘要
This study has completed enrollment of all 16 participants. Pharmacokinetic data has been obtained on all patients. This clinical trial has ended and data analysis is underway. Chronocort is a modified release therapy that delivers hydrocortisone in a manner that mimics the bodys normal circadian rhythm (the bodys natural, 24-hour hormone cycle). This therapeutic approach has the potential to help patients suffering from diseases due to cortisol deficiency: congenital adrenal hyperplasia and adrenal insufficiency. Each of these diseases requires life-long treatment and this novel approach to drug delivery has the potential to significantly improve patients lives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 2 Multi-center Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
  • 批准号:
    10252568
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Deborah Merke
  • 依托单位:
Novel treatment approaches: sex steroid blockade in children
  • 批准号:
    10916862
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Deborah Merke
  • 依托单位:
Study of a corticotropin releasing factor-1 receptor antagonist for the treatment of congenital adrenal hyperplasia
  • 批准号:
    10916863
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Deborah Merke
  • 依托单位:
海外基金